- Видео 250
- Просмотров 82 799
Mtech Access
Великобритания
Добавлен 9 сен 2016
At Mtech Access--Powered by Petauri™, we partner with Pharma and Medtech leaders to drive optimal global commercialisation. Programmes of support include:
•\tEvidence, pricing and access strategy
•\tDevelopment of a robust evidence base
•\tNational, regional and local reimbursement, and formulary inclusion
•\tCommunication of value to clinical and financial decision-makers
Follow our channel for insights from our in-house market access and HEOR specialists, as well as our external network of healthcare professionals and other stakeholders. Our videos offer:
- Insights into the NHS and other global healthcare systems
- Discussion of the latest trends in market access
- Explanation and discussion of health economics and evidence generation techniques
- Demos of our innovative digital presentation aids and dashboards
•\tEvidence, pricing and access strategy
•\tDevelopment of a robust evidence base
•\tNational, regional and local reimbursement, and formulary inclusion
•\tCommunication of value to clinical and financial decision-makers
Follow our channel for insights from our in-house market access and HEOR specialists, as well as our external network of healthcare professionals and other stakeholders. Our videos offer:
- Insights into the NHS and other global healthcare systems
- Discussion of the latest trends in market access
- Explanation and discussion of health economics and evidence generation techniques
- Demos of our innovative digital presentation aids and dashboards
Where and how is medicines strategy explored in the NHS?
In this clip from a recent NHS Whispers webinar, Jack Wagstaff (Place Leader, Surrey Heartlands Health
and Care Partnership, Chief Officer for North West Surrey Health and Care Alliance) discusses the management of medicines, and the impact of costs and national supply chain vulnerabilities.
Jack recommends that, when considering costs, it is important to factor in other effects on the wider pathway beyond a simple price comparison. He calls for more strategic partnerships with industry to explore the wider impact of medicines and devices on the overall care pathway.
We can help you map out the care pathway and develop models and materials that support conversations with NHS leaders. To spe...
and Care Partnership, Chief Officer for North West Surrey Health and Care Alliance) discusses the management of medicines, and the impact of costs and national supply chain vulnerabilities.
Jack recommends that, when considering costs, it is important to factor in other effects on the wider pathway beyond a simple price comparison. He calls for more strategic partnerships with industry to explore the wider impact of medicines and devices on the overall care pathway.
We can help you map out the care pathway and develop models and materials that support conversations with NHS leaders. To spe...
Просмотров: 5
Видео
NHS primary care panel - the GP Contract and Operational Planning Guidance
Просмотров 15321 час назад
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future of primary care? What are the biggest challenges facing primary care in 2024-25? In this webinar, Karen Cooper (Senior Consultant - NHS Insight & Interaction, Mtech Access) spoke to a panel of NHS Associates about the current stat...
Engage NHS healthcare decision-makers with RWD
Просмотров 81Месяц назад
Discover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with RWD within a well-designed, easy-to-use visualisation can build a case for change, while positioning themselves as a trusted partner. Watch this 20-minute discussion between I...
How do price negotiations for pharmaceuticals work in Canada?
Просмотров 452 месяца назад
How do price negotiations for pharmaceuticals work in Canada? Don Husereau (Adjunct Professor of Medicine, The University of Ottawa) explains. What does this mean for your market access and pricing strategy? Email info@mtechaccess.co.uk to discuss your strategy with our experts. This clip is taken from a recent Global Whispers webinar (first broadcast live in March 2024), which is now available...
Why are CADTH conditionally approving therapies?
Просмотров 312 месяца назад
Did you know that the Canadian Agency for Drugs and Technologies in Health (CADTH) can now conditionally approve a therapy, rather than offering a definite yes or no? Here, Don Husereau (Adjunct Professor of Medicine, The University of Ottawa) explains that CADTH are taking this approach when they want to see more evidence for a therapy before signing off on reimbursement, but don't want to del...
Patient access challenges for orphan medicines in the Nordic region
Просмотров 552 месяца назад
In this short clip from our webinar on launching orphan drugs in secondary markets, Michelle James (Consultant - Global Market Access) tells us about HTA structures and access challenges in the Nordic region. Watch the full webinar, now available on demand and via our podcast, at: mtechaccess.co.uk/rare-disease-market-access-nordic-and-mena/
Patient access challenges for rare diseases in the MENA region
Просмотров 292 месяца назад
In this short clip from our webinar on launching orphan drugs in secondary markets, Robert Taaffe (Consultant - Global Market Access) tells us about patient access challenges in the MENA region. Watch the full webinar, now available on-demand and via our podcast, at: mtechaccess.co.uk/rare-disease-market-access-nordic-and-mena/
What is a partitioned survival model?
Просмотров 3483 месяца назад
What is a partitioned survival model? In this clip, Hannah Gillies (Senior Consultant - Health Economics) explains how partitioned survival models are used in health economics, along with their strengths and weaknesses for healthcare decision-making. Watch the full webinar: 'De-mystifying health economic model classifications and structures' on demand at: mtechaccess.co.uk/de-mystifying-health-...
What is a Cox regression model?
Просмотров 3353 месяца назад
In this clip, Daniel MacDonald (Associate Consultant - Health Economics) explains how Cox regression models are used in health economics, along with their strengths and weaknesses for healthcare decision-making. Watch the full webinar: 'De-mystifying health economic model classifications and structures' on demand at: mtechaccess.co.uk/de-mystifying-health-economic-models/ To speak to our expert...
Market access and reimbursement in Canada - changes at CADTH
Просмотров 2793 месяца назад
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? In this webinar, Clare Foy (Director - Global Market Access, Mtech Access) interviewed Don Husereau (Adjunct Professor of Medicine, The University of Ottawa). We take a look at the market access, heal...
What is a discrete event simulation in health economics?
Просмотров 2723 месяца назад
Hannah Gillies (Senior Consultant - Health Economics) explains how discrete event simulations are used in health economic modelling, along with their strengths and shortcomings for healthcare decision-making. Watch the full webinar: 'De-mystifying health economic model classifications and structures' on demand at: mtechaccess.co.uk/de-mystifying-health-economic-models/ To speak to our experts a...
What is the vision for primary care provider collaboratives in the NHS?
Просмотров 534 месяца назад
In this clip, Richard Smale (Interim Director of System Co-ordination, NHS England - South West) explains that we can't focus on structural changes without first asking what difference this will make for patients. Does your proposition support the move towards provider collaboratives? Can you help provider collaboratives drive efficiency? More importantly, can your product help improve the path...
What is a Markov model? - Health economics model structures
Просмотров 2694 месяца назад
In this clip, Hannah Gillies (Senior Consultant - Health Economics, Mtech Access) explains how they are used in health economics, along with their strengths and weaknesses for healthcare decision-making. Watch the full webinar (first broadcast live in January 2024): 'De-mystifying health economic model classifications and structures' on demand now at: mtechaccess.co.uk/de-mystifying-health-econ...
3 challenges your proposal must address for NHS decision-makers
Просмотров 304 месяца назад
According to Dr Viren Mehta (GP Partner, GP Federation Chief Officer, Viaduct Care), proposals from industry must have a compelling argument in each of these three areas to even be considered by NHS decision-makers: 1) Improving lives and outcomes for patients 2) Making working lives easier or better for NHS staff 3) Addressing long-term financial sustainability Does you value proposition addre...
Rare Disease market access in the MENA and Nordic regions
Просмотров 2154 месяца назад
Rare Disease market access in the MENA and Nordic regions
What is a decision tree and how is it used in health economics?
Просмотров 2784 месяца назад
What is a decision tree and how is it used in health economics?
Does your medical device or diagnostic empower patients?
Просмотров 254 месяца назад
Does your medical device or diagnostic empower patients?
Optimising NHS funding decisions: focusing on outcomes and ROI
Просмотров 2364 месяца назад
Optimising NHS funding decisions: focusing on outcomes and ROI
Opportunities to support secondary care in the NHS
Просмотров 474 месяца назад
Opportunities to support secondary care in the NHS
Introducing Mtech Access - Leaders in Global Pharma and Medtech Commercialisation
Просмотров 484 месяца назад
Introducing Mtech Access - Leaders in Global Pharma and Medtech Commercialisation
Health economic evaluation for HTA in different markets
Просмотров 2274 месяца назад
Health economic evaluation for HTA in different markets
How does funding flow in NHSE Regions?
Просмотров 4125 месяцев назад
How does funding flow in NHSE Regions?
NHS policy for 2024/25: strategy and engagement in a world of uncertainty
Просмотров 2385 месяцев назад
NHS policy for 2024/25: strategy and engagement in a world of uncertainty
Get payer input and feedback on your evidence strategy early
Просмотров 2005 месяцев назад
Get payer input and feedback on your evidence strategy early
De-mystifying health economic model classifications and structures
Просмотров 7845 месяцев назад
De-mystifying health economic model classifications and structures
Is it worth investing time to launch in NHS Wales?
Просмотров 195 месяцев назад
Is it worth investing time to launch in NHS Wales?
How does specialised commissioning work in Wales?
Просмотров 255 месяцев назад
How does specialised commissioning work in Wales?
6 key early decisions when launching new Pharma and Medtech products
Просмотров 2126 месяцев назад
6 key early decisions when launching new Pharma and Medtech products
What would the NHS in Wales want to see from an industry partner?
Просмотров 806 месяцев назад
What would the NHS in Wales want to see from an industry partner?
Evidence strategy for Medical Technologies and Diagnostics
Просмотров 1086 месяцев назад
Evidence strategy for Medical Technologies and Diagnostics
Thank you for this explanation. Applying for a specialist nurse job and ICB has been a topic I’ve been asked to make a presentation on, super helpful.
Glad it was helpful. Best of luck with your interview!
Tremendous
Phenotype = Genotype and Environment
Sorry where is the question pole please how do I get it?
Sorry the poll was only available to those viewing live in the original webinar. This is a recording. Subscribe to our newsletter mtechaccess.co.uk/subscribe/ to hear about our upcoming webinars and interact live.
Amazing networking for the benefit of all
Love this job used to work there😁
Superb synopsis of the challenges to shape care into more accessible and efficient pathways. Thank you.
Thank you - glad you found it so helpful.
Hello mtech, Whats the best way to get in touch with you?
Drop us an email at info@mtechaccess.co.uk.
I applaud Liz’s statement about how (sometimes) the NHS does not know what Patients want & some decisions about ‘how patients want to access care’ or ‘what matters to patients’ are based on assumptions. This is why Patient Collaboration at all levels is crucial especially when developing the post-COVID19 plan for patients with long-term conditions. If you’re interested, I can connect you with David Gilbert, who is doing some work around Patient Leaders/Leadership (as agents of change & collaboration) in the NHS. You can reply this or email stuartdodzo@gmail.com 🙂
Dear Stuart. Thank you for your helpful and insightful point. We will make sure Liz Cross is aware of your feedback. We know that you are in touch with David Thorne, one of our Directors, and he will follow this up with you. We love challenging assumptions and the associated learning gained by being close to people’s real experience of health care. Please continue to watch our videos and give us your excellent advice. David will be in contact.
Thanks! This was really useful.